Health Technology Sysmex Corp. Business Summary
Sysmex Corp. engages in the healthcare business. It develops, manufactures, sells, exports, and imports diagnostic instruments, reagents. and software used in in-vitro diagnostics. It also provides clinical laboratory testing of blood, urine, and other specimens. Its products include instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis, and point-of-care (POC) testing. It operates through the following geographical segments: Japan, Americas, Europe, Middle East, and Africa (EMEA), China, and Asia Pacific. The company was founded by Taro Nakatani on February 20, 1968 and is headquartered in Kobe, Japan.
Financial Highlights
Mar 2022
JPY USD Revenue 363,780M 3,237.26M Gross Profit 190,585M 1,696.00M Operating income 69,566M 619.06M Income before tax 67,907M 604.30M Net income 44,092M 392.37M EBITDA 96,997M 863.17M Diluted EPS 210.49 1.87 Dividends Per Share 76 0.67 Total Assets 483,707M 3,985.22M Total liabilities 134,898M 1,111.41M Total equity 348,303M 2,869.64M Operating cash flow 58,739M 522.71M Currency in JPY Currency in USD
Historical Data Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Revenue
281,935M
293,506M
301,980M
305,073M
363,780M
Gross Profit
158,949M
161,607M
159,807M
154,303M
190,585M
Operating income
59,947M
60,799M
54,501M
49,165M
69,566M
Income before tax
58,117M
57,955M
49,433M
49,334M
67,907M
Net income
39,221M
41,224M
34,882M
31,904M
44,092M
EBITDA
74,590M
76,641M
78,456M
74,581M
96,997M
Diluted EPS
187.84
197.28
166.92
152.47
210.49
Dividends Per Share
66
70
72
72
76
Total Assets
321,979M
346,775M
389,291M
424,895M
483,707M
Total liabilities
80,531M
81,588M
110,941M
118,955M
134,898M
Total equity
240,750M
264,449M
277,684M
305,318M
348,303M
Operating cash flow
52,240M
44,743M
53,182M
56,873M
58,739M
Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Revenue
2,543.79M
2,646.70M
2,777.44M
2,876.48M
3,237.26M
Gross Profit
1,434.13M
1,457.30M
1,469.81M
1,454.90M
1,696.00M
Operating income
540.87M
548.25M
501.27M
463.56M
619.06M
Income before tax
524.36M
522.61M
454.65M
465.16M
604.30M
Net income
353.87M
371.74M
320.82M
300.81M
392.37M
EBITDA
672.99M
691.11M
721.59M
703.21M
863.17M
Diluted EPS
1.69
1.77
1.53
1.43
1.87
Dividends Per Share
0.59
0.63
0.66
0.67
0.67
Total Assets
3,027.54M
3,132.99M
3,606.04M
3,845.20M
3,985.22M
Total liabilities
757.22M
737.11M
1,027.65M
1,076.51M
1,111.41M
Total equity
2,263.75M
2,389.20M
2,572.21M
2,763.05M
2,869.64M
Operating cash flow
471.34M
403.47M
489.13M
536.24M
522.71M
Valuation Measures
Mar 2022
PER 42.31 ROA 9.70% ROE 13.49% Operating margin 19.12% Profit margin 12.12%
Key executives
Chairman, Chief Executive Officer & President:
Hisashi Ietsugu
Director, CTO & COO-LS Business Unit:
Kaoru Asano
CFO, Director & Senior Managing Executive Officer:
Yukio Nakajima
Manager-Informatics:
Yasuhiro Takachi
Executive Officer:
Keiji Fujimoto Shareholders
Baillie Gifford & Co. (5.9%)
Kobe Yamabuki Foundation (5.7%)
Nakatani Foundation (5.6%)
Nakatani Kosan YK (4.9%)
IETSUGU KAZUKO (2.9%)
WADA TAEKO (2.9%)
BlackRock Fund Advisors (2.7%)
Nomura Asset Management Co., Ltd. (2.6%)
The Vanguard Group, Inc. (2.3%)
IETSUGU FAMILY (2.2%)
Contact Details Website: http://www.sysmex.co.jp Address:
1-5-1 Wakinohama-Kaigandori,
Chuo-Ku,
Kobe,
651-0073,
Japan
Phone:
+81.78.265.0500
Related Companies
Sysmex Pilot Co. Ltd.
Sysmex Astrego AB
Oxford Gene Technology (Operations) Ltd.
Astrego Diagnostics AB
Sysmex Medical Electronics (Shanghai) Co., Ltd.
Sysmex Wuxi Co. Ltd.
Sysmex Inostics, Inc.
Sysmex Turkey Diagnostik Sistemleri Ltd. STI
Sysmex (Malaysia) Sdn.Bhd.
Sysmex Vietnam Co. Ltd.
Sysmex Taiwan Co. Ltd.
Sysmex Suisse AG
Sysmex Slovakia sro
Sysmex Shanghai Ltd.
Sysmex RUS LLC
Sysmex Polska Sp zoo
Sysmex Philippines, Inc.
Sysmex Hungaria Kft.
Sysmex Hong Kong Ltd.
Sysmex Espana SL
Sysmex do Brasil Industria e Comercio Ltda.
Sysmex CZ sro
Sysmex Canada, Inc.
Sysmex Austria GmbH
Sysmex Middle East FZ LLC
Sysmex South Africa (Pty) Ltd.
Sysmex Inostics GmbH
Sysmex Korea Co., Ltd.
Katakura Industries Co. Ltd. /Biological Research Center/
Sysmex RA Co. Ltd.
Competitors
Guardant Health, Inc.
Haemonetics Corporation
Exact Sciences Corporation
Biocept, Inc.
SD Biosensor, Inc.
Epigenomics AG
Hangzhou Biotest Biotech Co., Ltd. Class A
Copyright © 2022 FactSet Research Systems Inc. All rights reserved.
Last Updated on 16 Aug, 2022
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.
Celebrate our next chapter
Free access for everyone - Sep. 30
Find out more
By continuing to browse this website, you accept cookies which are used for several reasons such as personalizing content/ads and analyzing how this website is used. Please review our
Cookie Policy
to learn how you can update your cookie settings.
Accept & Continue
Close